Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong
· Delayed Price · Currency is HKD 39.98
+1.32 (3.41%)
Apr 29, 2026, 4:08 PM HKT
HKG:1501 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,065 | 851.95 | 752.84 | 585.88 | 464.68 | Upgrade
|
| Revenue Growth (YoY) | 25.06% | 13.17% | 28.50% | 26.08% | 29.64% | Upgrade
|
| Cost of Revenue | 428.69 | 314.29 | 314.77 | 253.4 | 188.93 | Upgrade
|
| Gross Profit | 636.79 | 537.66 | 438.07 | 332.49 | 275.75 | Upgrade
|
| Selling, General & Admin | 266.05 | 200.23 | 166.82 | 120.68 | 79.07 | Upgrade
|
| Research & Development | 150.06 | 149.13 | 125.85 | 99.63 | 89.96 | Upgrade
|
| Other Operating Expenses | -37.4 | -23.1 | -17 | -18.1 | -38.49 | Upgrade
|
| Operating Expenses | 378.49 | 325.64 | 276.08 | 203.14 | 131.11 | Upgrade
|
| Operating Income | 258.29 | 212.02 | 161.99 | 129.34 | 144.64 | Upgrade
|
| Interest Expense | -12.54 | -2.43 | -3.19 | -0.82 | -0.63 | Upgrade
|
| Interest & Investment Income | 11.99 | 9.11 | 11.83 | 13.41 | 14.53 | Upgrade
|
| Earnings From Equity Investments | -0.59 | -0.4 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -5.98 | 3.11 | 2.42 | 2.54 | -2.84 | Upgrade
|
| EBT Excluding Unusual Items | 251.17 | 221.41 | 173.05 | 144.47 | 155.69 | Upgrade
|
| Gain (Loss) on Sale of Investments | 7.15 | -8.03 | 2.08 | - | - | Upgrade
|
| Pretax Income | 258.32 | 213.38 | 175.13 | 144.47 | 155.69 | Upgrade
|
| Income Tax Expense | 25.65 | 23.34 | 21.9 | 10.64 | 15.25 | Upgrade
|
| Earnings From Continuing Operations | 232.67 | 190.05 | 153.23 | 133.83 | 140.45 | Upgrade
|
| Minority Interest in Earnings | -13.89 | 1.87 | 3.23 | -2.12 | 2.52 | Upgrade
|
| Net Income | 218.79 | 191.91 | 156.46 | 131.71 | 142.96 | Upgrade
|
| Preferred Dividends & Other Adjustments | 12.56 | 11 | 4.58 | 1.57 | - | Upgrade
|
| Net Income to Common | 206.23 | 180.92 | 151.88 | 130.15 | 142.96 | Upgrade
|
| Net Income Growth | 14.00% | 22.66% | 18.79% | -7.87% | 17.80% | Upgrade
|
| Shares Outstanding (Basic) | 164 | 165 | 166 | 166 | 166 | Upgrade
|
| Shares Outstanding (Diluted) | 172 | 171 | 171 | 169 | 167 | Upgrade
|
| Shares Change (YoY) | 0.92% | -0.11% | 1.10% | 1.32% | 0.48% | Upgrade
|
| EPS (Basic) | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 | Upgrade
|
| EPS (Diluted) | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 | Upgrade
|
| EPS Growth | 14.17% | 20.10% | 17.49% | -9.38% | 17.81% | Upgrade
|
| Free Cash Flow | 283.63 | 99.8 | 9.31 | -62.75 | -205.07 | Upgrade
|
| Free Cash Flow Per Share | 1.65 | 0.58 | 0.05 | -0.37 | -1.23 | Upgrade
|
| Dividend Per Share | 0.230 | - | 0.270 | 0.240 | 0.260 | Upgrade
|
| Dividend Growth | - | - | 12.50% | -7.69% | -8.77% | Upgrade
|
| Gross Margin | 59.77% | 63.11% | 58.19% | 56.75% | 59.34% | Upgrade
|
| Operating Margin | 24.24% | 24.89% | 21.52% | 22.08% | 31.13% | Upgrade
|
| Profit Margin | 19.36% | 21.24% | 20.18% | 22.21% | 30.77% | Upgrade
|
| Free Cash Flow Margin | 26.62% | 11.71% | 1.24% | -10.71% | -44.13% | Upgrade
|
| EBITDA | 353.06 | 286.75 | 204.78 | 159.99 | 168.81 | Upgrade
|
| EBITDA Margin | 33.14% | 33.66% | 27.20% | 27.31% | 36.33% | Upgrade
|
| D&A For EBITDA | 94.77 | 74.73 | 42.79 | 30.65 | 24.17 | Upgrade
|
| EBIT | 258.29 | 212.02 | 161.99 | 129.34 | 144.64 | Upgrade
|
| EBIT Margin | 24.24% | 24.89% | 21.52% | 22.08% | 31.13% | Upgrade
|
| Effective Tax Rate | 9.93% | 10.94% | 12.50% | 7.36% | 9.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.